ELITechGroup received the CE mark for Saliva on SARS-CoV-2 ELITe MGB® Kit
August 5, 2021
ITALY, Torino, August 3rd, 2021. ELITechGroup is pleased to announce the CE mark for use of saliva on SARS-CoV-2 ELITe MGB® Kit. The collection of saliva matrix is less invasive for SARS-CoV-2 detection than nasopharyngeal swabs and will permit to address different needs starting from repeated screening in various settings such as schools and workplaces.
“ELITechGroup is constantly committed to improving both test quality and sample matrices collected. For this reason, we identified the use of saliva for SARS-CoV-2 as crucial for reopening schools and community life” says Roberto Meda, Vice President MDx ELITechGroup.
The CE-IVD marked Kit detecting SARS-CoV-2 and validated on nasopharyngeal, nasal and oropharyngeal swabs has been released on September 2020 on the Sample-to Result-Platform ELITe InGenius® and on major PCR thermocyclers as well.
About ELITechGroup: ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents. By bringing together IVD specialty companies that offer innovative products and solutions, ELITechGroup has become a major contributor in advancing clinical diagnostics to laboratories in the proximity market, those operating closer to the patient.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
